Rhythm Biosciences (FRA:0RY) Total Stockholders Equity : €0.76 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Rhythm Biosciences Total Stockholders Equity?

Rhythm Biosciences's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €0.76 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Rhythm Biosciences's Book Value per Share for the quarter that ended in Dec. 2023 was €0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Rhythm Biosciences's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.03.

Rhythm Biosciences Total Stockholders Equity Historical Data

The historical data trend for Rhythm Biosciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Biosciences Total Stockholders Equity Chart

Rhythm Biosciences Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

Get a 7-Day Free Trial

3.60

1.13

1.08

4.90

3.64

Rhythm Biosciences Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial								3.36	4.90	5.60	3.64	0.76

Rhythm Biosciences (FRA:0RY) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Rhythm Biosciences's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(0.763	-	0)	/	225.881
	=	0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Rhythm Biosciences's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.024	+	0)	/	0.763
	=	0.03

Rhythm Biosciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Rhythm Biosciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Biosciences (FRA:0RY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (FRA:0RY) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

RHY:Australia

Address

30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010

Website

https://www.rhythmbio.com

Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.

Rhythm Biosciences (FRA:0RY) Headlines

No Headlines